Global Classical Swine Fever Vaccines Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033

According to DIResearch＇s in-depth investigation and research, the global Classical Swine Fever Vaccines market size will reach 191.93 Million USD in 2026 and is projected to reach 266.66 Million USD by 2033, with a CAGR of 4.81% (2026-2033). Notably, the China Classical Swine Fever Vaccines market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Classical swine fever vaccines are vaccines developed to protect pigs from classical swine fever (CSF), also known as hog cholera. CSF is a highly contagious viral disease that affects domestic and wild pigs, causing significant economic losses in the swine industry. The vaccines are designed to stimulate the pig＇s immune system to produce protective antibodies against the CSF virus, preventing infection and reducing the severity of the disease if exposure occurs. Classical swine fever vaccines can be divided into two main categories: live attenuated vaccines and inactivated vaccines. Live attenuated vaccines contain weakened forms of the CSF virus, while inactivated vaccines contain killed virus particles. Both types of vaccines have proven effective in controlling and preventing the spread of the disease. Vaccination is a crucial tool in CSF control and eradication programs, especially in areas where the disease is endemic or in situations where outbreaks occur. Proper vaccination protocols, biosecurity measures, and surveillance are essential components of a comprehensive strategy to protect swine herds and ensure the health and productivity of the pig industry.

The major global suppliers of Classical Swine Fever Vaccines include Winsun Bio-Pharmaceutical, MSD Animal Health, CAHIC, Tecon, SPAH, Boehringer Ingelheim, Ceva, Harbin Weike BIOTECHNOLOGY, Qilu Animal Health Products, Ringpu Bio-Technology, DaHuaNong Animal Health Products, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, Institutul Pasteur, MVP, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Classical Swine Fever Vaccines. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Classical Swine Fever Vaccines market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Classical Swine Fever Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Classical Swine Fever Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Classical Swine Fever Vaccines Include:

Winsun Bio-Pharmaceutical

MSD Animal Health

CAHIC

Tecon

SPAH

Boehringer Ingelheim

Ceva

Harbin Weike BIOTECHNOLOGY

Qilu Animal Health Products

Ringpu Bio-Technology

DaHuaNong Animal Health Products

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Institutul Pasteur

MVP

Classical Swine Fever Vaccines Product Segment Include:

C-Strain Live Attenuated Vaccine

Thiverval Strain Vaccine

Others

Classical Swine Fever Vaccines Product Application Include:

Government Tender

Market Sales

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Classical Swine Fever Vaccines Industry PESTEL Analysis

Chapter 3: Global Classical Swine Fever Vaccines Industry Porter's Five Forces Analysis

Chapter 4: Global Classical Swine Fever Vaccines Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Classical Swine Fever Vaccines Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Classical Swine Fever Vaccines Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Classical Swine Fever Vaccines Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources

Table 1： Classical Swine Fever Vaccines Industry Development Status

Table 2： Classical Swine Fever Vaccines Industry Development Trends

Table 3： Global Classical Swine Fever Vaccines Revenue and Growth Rate (CAGR) by Country: 2025 VS 2026 VS 2033 (US$ Million)

Table 4： Global Classical Swine Fever Vaccines Revenue by Country (2021-2026) & (US$ Million)

Table 5： Global Classical Swine Fever Vaccines Revenue Market Share by Country (2021-2026)

Table 6： Global Classical Swine Fever Vaccines Revenue Forecast by Country (2027-2033) & (US$ Million)

Table 7： Global Classical Swine Fever Vaccines Revenue Market Share Forecast by Country (2027-2033)

Table 8： Global Classical Swine Fever Vaccines Market Revenue by Key Suppliers (2021-2026) & (US$ Million)

Table 9： Global Classical Swine Fever Vaccines Revenue Market Share by Key Suppliers (2021-2026)

Table 10： Global Key Suppliers Headquarter and Key Area Sales

Table 11： Market Mergers & Acquisitions, Expansion

Table 12： Global Classical Swine Fever Vaccines Market Size and Growth Rate (CAGR) Analysis by Type: 2025 VS 2026 VS 2033 (US$ Million)

Table 13： Global Classical Swine Fever Vaccines Revenue Analysis by Type (2021-2026) & (US$ Million)

Table 14： Global Classical Swine Fever Vaccines Revenue Forecast Analysis by Type (2027-2033) & (US$ Million)

Table 15： Winsun Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 16： Winsun Bio-Pharmaceutical Classical Swine Fever Vaccines Product Portfolio

Table 17： Winsun Bio-Pharmaceutical Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 18： MSD Animal Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 19： MSD Animal Health Classical Swine Fever Vaccines Product Portfolio

Table 20： MSD Animal Health Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 21： CAHIC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 22： CAHIC Classical Swine Fever Vaccines Product Portfolio

Table 23： CAHIC Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 24： Tecon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 25： Tecon Classical Swine Fever Vaccines Product Portfolio

Table 26： Tecon Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 27： SPAH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 28： SPAH Classical Swine Fever Vaccines Product Portfolio

Table 29： SPAH Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 30： Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 31： Boehringer Ingelheim Classical Swine Fever Vaccines Product Portfolio

Table 32： Boehringer Ingelheim Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 33： Ceva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 34： Ceva Classical Swine Fever Vaccines Product Portfolio

Table 35： Ceva Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 36： Harbin Weike BIOTECHNOLOGY Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 37： Harbin Weike BIOTECHNOLOGY Classical Swine Fever Vaccines Product Portfolio

Table 38： Harbin Weike BIOTECHNOLOGY Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 39： Qilu Animal Health Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 40： Qilu Animal Health Products Classical Swine Fever Vaccines Product Portfolio

Table 41： Qilu Animal Health Products Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 42： Ringpu Bio-Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 43： Ringpu Bio-Technology Classical Swine Fever Vaccines Product Portfolio

Table 44： Ringpu Bio-Technology Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 45： DaHuaNong Animal Health Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 46： DaHuaNong Animal Health Products Classical Swine Fever Vaccines Product Portfolio

Table 47： DaHuaNong Animal Health Products Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 48： CAVAC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 49： CAVAC Classical Swine Fever Vaccines Product Portfolio

Table 50： CAVAC Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 51： Komipharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 52： Komipharm Classical Swine Fever Vaccines Product Portfolio

Table 53： Komipharm Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 54： Agrovet Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 55： Agrovet Classical Swine Fever Vaccines Product Portfolio

Table 56： Agrovet Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 57： Bioveta Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 58： Bioveta Classical Swine Fever Vaccines Product Portfolio

Table 59： Bioveta Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 60： Jinyu Bio-Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 61： Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio

Table 62： Jinyu Bio-Technology Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 63： Institutul Pasteur Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 64： Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio

Table 65： Institutul Pasteur Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 66： MVP Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 67： MVP Classical Swine Fever Vaccines Product Portfolio

Table 68： MVP Classical Swine Fever Vaccines Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 69： Global Classical Swine Fever Vaccines Market Size and Growth Rate (CAGR) by Application: 2025 VS 2026 VS 2033 & (US$ Million)

Table 70： Global Classical Swine Fever Vaccines Revenue Analysis by Application (2021-2026) & (US$ Million)

Table 71： Global Classical Swine Fever Vaccines Revenue Forecast Analysis by Application (2027-2033) & (US$ Million)

Table 72： Classical Swine Fever Vaccines Typical Customer List

Table 73： Classical Swine Fever Vaccines Distributors List

Figure 1： Classical Swine Fever Vaccines Product Pictures

Figure 2： C-Strain Live Attenuated Vaccine Picture Scope

Figure 3： Thiverval Strain Vaccine Picture Scope

Figure 4： Others Picture Scope

Figure 5： Government Tender Picture Scope

Figure 6： Market Sales Picture Scope

Figure 7： Global Classical Swine Fever Vaccines Market Size Analysis：2025 VS 2026 VS 2033 (US$ Million)

Figure 8： Global Classical Swine Fever Vaccines Market Revenue and Growth Rate Analysis: (2021-2033) & (US$ Million)

Figure 9： Global Classical Swine Fever Vaccines Revenue Market Share by Country in 2025

Figure 10： United States Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 11： Germany Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 12： Japan Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 13： China Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 14： France Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 15： U.K. Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 16： South Korea Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 17： Canada Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 18： Italy Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 19： Russia Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 20： Mexico Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 21： Brazil Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 22： India Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 23： Vietnam Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 24： Thailand Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 25： South Africa Classical Swine Fever Vaccines Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 26： Global Classical Swine Fever Vaccines Revenue Market Share by Key Suppliers in 2025

Figure 27： Global Classical Swine Fever Vaccines Industry Competition Landscape

Figure 28： Global Classical Swine Fever Vaccines Market Size by Type (2021-2033) (US$ Million)

Figure 29： Global Classical Swine Fever Vaccines Market Share by Type: 2026 & 2033

Figure 30： Classical Swine Fever Vaccines Industry Chain Analysis

Figure 31： Global Classical Swine Fever Vaccines Revenue Market Share by Application (2021-2033)

Figure 32： Key Interview Objectives

Figure 33： Bottom-Up and Top-Down Research Methods